← Back to Search

Behavioral Intervention

Wearable Tech for Sleep Apnea Management (mPAP Trial)

N/A
Recruiting
Led By Constance H. Fung, MD, MSHS
Research Sponsored by VA Greater Los Angeles Healthcare System
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Prescribed PAP therapy from the sleep center for > 1 week
Non-adherent with PAP therapy
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 weeks
Awards & highlights

mPAP Trial Summary

This trial will test if a new program with wearable tech and personalized reports can help adults with sleep apnea better use their prescribed therapy.

Who is the study for?
This trial is for adults with obstructive sleep apnea who have been prescribed positive airway pressure therapy but aren't using it as recommended. They must be willing to use their current PAP device for 28 days and have a compatible electronic device for the wearable app. People with unstable illnesses, planned surgeries, or certain conditions like heart failure are not eligible.Check my eligibility
What is being tested?
The study is testing a new program that uses consumer wearables to monitor oxygen levels during sleep and provides weekly reports. It aims to see if this leads to better use of positive airway pressure therapy compared to those receiving usual care without the immediate intervention.See study design
What are the potential side effects?
Since this trial involves non-invasive monitoring through wearable devices, there may be minimal side effects such as skin irritation from the wearable, discomfort from increased awareness of health data, or privacy concerns related to data sharing.

mPAP Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been using a PAP machine for sleep for over a week.
Select...
I have not followed my prescribed PAP therapy.
Select...
I am willing to use my current sleep apnea device for 28 days straight.

mPAP Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
PAP adherence (minutes)
Secondary outcome measures
PAP adherence (percent of days used >= 4 hours)

mPAP Trial Design

2Treatment groups
Experimental Treatment
Group I: Waitlist controlExperimental Treatment1 Intervention
Participants will receive usual care from the sleep center for 6 weeks and then be provided with a consumer wearable to wear for 4 weeks.
Group II: Immediate InterventionExperimental Treatment1 Intervention
Participants will be provided with a consumer wearable immediately after randomization to wear for 4 weeks.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Immediate Intervention
2017
N/A
~1940
Waitlist control
2007
Completed Phase 2
~2450

Find a Location

Who is running the clinical trial?

University of California, Los AngelesOTHER
1,532 Previous Clinical Trials
10,265,218 Total Patients Enrolled
VA Greater Los Angeles Healthcare SystemLead Sponsor
51 Previous Clinical Trials
8,519 Total Patients Enrolled
Constance H. Fung, MD, MSHSPrincipal InvestigatorVA Greater Los Angeles Healthcare System

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any openings remaining to participate in this research?

"The records on clinicaltrials.gov confirm that this experiment is no longer recruiting participants; it was originally posted on September 12th 2023 and last updated the 8th of the same month. Despite this, there are still 283 other trials currently in need of candidates."

Answered by AI

Who else is applying?

What site did they apply to?
VA Greater Los Angeles Healthcare System
What portion of applicants met pre-screening criteria?
Did not meet criteria
~23 spots leftby Sep 2024